» Articles » PMID: 29137951

Triple-Negative Breast Cancer, Stem Cells, and African Ancestry

Overview
Journal Am J Pathol
Publisher Elsevier
Specialty Pathology
Date 2017 Nov 16
PMID 29137951
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Triple-negative breast cancers (TNBCs) are more common among African-ancestry populations, such as African Americans and western, sub-Saharan Africans, compared with European-ancestry populations. This phenotype prevalence contributes to disparities in breast cancer outcomes between African Americans and White Americans. Breast cancer stem cells represent the tumor subpopulation involved in metastatic virulence, and ongoing research seeks to characterize the extent to which TNBC versus non-TNBC stem cells may differ. This review summarizes the existing literature regarding TNBCs and stem cells as they pertain to the burden of breast cancer among African-ancestry populations. Additional research related to variations in somatic tumor genomics between the African-American and White-American populations is also summarized. This review furthermore explores the history of insights regarding breast cancer disparities related to racial/ethnic identity, socioeconomic status, and tumor biology.

Citing Articles

The Current State of Breast Cancer Genetics in Populations of African Ancestry.

Cupertino S, Goncalves A, Gusmao Lopes C, Gradia D, Beltrame M Genes (Basel). 2025; 16(2).

PMID: 40004528 PMC: 11855290. DOI: 10.3390/genes16020199.


West African Genetic Ancestry and Breast Cancer Outcomes Among Black Women.

Reid S, Fan R, Venton L, Weidner A, Tezak A, Roberson M JAMA Netw Open. 2024; 7(12):e2449798.

PMID: 39652347 PMC: 11629124. DOI: 10.1001/jamanetworkopen.2024.49798.


A pH-triggered N-oxide polyzwitterionic nano-drug loaded system for the anti-tumor immunity activation research.

Zhao Y, Bai Y, Li M, Nie X, Meng H, Shosei S J Nanobiotechnology. 2024; 22(1):420.

PMID: 39014462 PMC: 11253471. DOI: 10.1186/s12951-024-02677-0.


The DARC side of genetics in cancer: Breast cancer disparities.

Martini R, Davis M Am J Hum Genet. 2024; 111(7):1261-1264.

PMID: 38996469 PMC: 11383922. DOI: 10.1016/j.ajhg.2024.05.011.


Temporal Association Rule Mining: Race-Based Patterns of Treatment-Adverse Events in Breast Cancer Patients Using SEER-Medicare Dataset.

Adam N, Wieder R Biomedicines. 2024; 12(6).

PMID: 38927419 PMC: 11200891. DOI: 10.3390/biomedicines12061213.